Ticker > Company >

Indegene share price

Indegene Ltd.

NSE: INDGN BSE: 544172 SECTOR: Business Support  69.24 K   62   32

575.20
-1.85 (-0.32%)
NSE: Today, 01:14 PM

Price Summary

Today's High

₹ 584.95

Today's Low

₹ 571.55

52 Week High

₹ 736.3

52 Week Low

₹ 499

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

13808.81 Cr.

Enterprise Value

13645.21 Cr.

No. of Shares

24.01 Cr.

P/E

76.17

P/B

7.46

Face Value

₹ 2

Div. Yield

0.35 %

Book Value (TTM)

₹  77.15

CASH

163.6 Cr.

DEBT

0 Cr.

Promoter Holding

0 %

EPS (TTM)

₹  7.55

Sales Growth

4.59%

ROE

13.07 %

ROCE

17.22%

Profit Growth

31.47 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year4.59%
3 Year9.34%
5 Year26.73%

Profit Growth

1 Year31.47%
3 Year10.96%
5 Year41.74%

ROE%

1 Year13.07%
3 Year15.87%
5 Year36.91%

ROCE %

1 Year17.22%
3 Year21.32%
5 Year31.33%

Debt/Equity

0

Price to Cash Flow

107.05

Interest Cover Ratio

39.4677

CFO/PAT (5 Yr. Avg.)

0.6725688589095

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 0.00 0.00
Dec 2024 0.00 0.00
Sep 2024 0.00 0.00
Jun 2024 0.00 0.00
Mar 2024 0.00 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROCE of 21.3163666666667% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 39.4677.
  • Company has a healthy liquidity position with current ratio of 6.4274.

 Limitations

  • The company has shown a poor revenue growth of 9.33583429915583% for the Past 3 years.
  • The company is trading at a high PE of 76.17.
  • The company is trading at a high EV/EBITDA of 50.6446.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 272.5 258.6 281.7 286.7 266.7
Total Expenditure 226.1 219.1 235.3 234.8 227.1
Operating Profit 46.4 39.5 46.4 51.9 39.6
Other Income 23.1 13.7 22.4 22.3 35.2
Interest 1.5 1.5 1.6 1.6 1.5
Depreciation 7.6 6.6 6.2 6.5 6.9
Exceptional Items 0 0 0 0 0
Profit Before Tax 60.4 45.1 61 66.1 66.4
Tax 11.5 12.5 16.2 16.2 12.2
Profit After Tax 48.9 32.6 44.8 49.9 54.2
Adjusted EPS (Rs) 2.2 1.36 1.87 2.09 2.26

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 511 836.7 1005.7 1045.6 1093.6
Total Expenditure 361 668 828.1 877.6 913.1
Operating Profit 150 168.7 177.6 168 180.5
Other Income 24.5 27.8 37.1 50.3 90.4
Interest 3.5 3 6.4 6.6 6.2
Depreciation 17.6 23.6 31.7 31.1 26.2
Exceptional Items 3 0 0 0 0
Profit Before Tax 156.4 169.9 176.6 180.6 238.5
Tax 26.9 37.2 46.4 42.7 57.2
Net Profit 132.4 132.7 130.2 137.9 181.3
Adjusted EPS (Rs.) 6.85 5.27 5.88 6.21 7.57

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 0.3 0.4 44.3 44.4 47.9
Total Reserves 253.6 649.6 751 909.4 1840.3
Borrowings 0 0 0 0 0
Other N/C liabilities 7.1 48.8 59.4 53.2 50.4
Current liabilities 93.3 140.7 169.4 198.1 189.5
Total Liabilities 354.3 839.5 1024.1 1205.1 2128.1
Assets
Net Block 40.6 72 78.3 56.1 52.8
Capital WIP 0 0 0 0 3.6
Intangible WIP 0 0 0 0 0
Investments 83.4 83.4 231.5 385.4 471.3
Loans & Advances 12.3 149.5 11.1 12.5 382
Other N/C Assets 0.1 0.1 0.3 0.1 0.4
Current Assets 217.9 534.5 702.9 751 1218
Total Assets 354.3 839.5 1024.1 1205.1 2128.1
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 159.9 169.9 176.6 180.6 238.5
Adjustment 11.3 15.5 32.8 2.5 -40.3
Changes in Assets & Liabilities -92.3 -111.3 -85.7 42.4 1.4
Tax Paid -25.6 -35.9 -41.8 -49.3 -70.6
Operating Cash Flow 53.3 38.2 81.9 176.2 129
Investing Cash Flow -34.1 -266.9 -51 -189 -824.3
Financing Cash Flow -37.1 244.9 -16.9 -15.8 717.3
Net Cash Flow -17.9 16.2 14 -28.6 22

Corporate Actions

Investors Details

 No Promoters Data available for this company.Report us
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 100.00 100.00 100.00 100.00 100.00
anand kiran 2.18 2.18 2.18 2.18 2.17
bpc genesis fund i a spv ... 3.26 3.26 3.26 3.26 3.25
bpc genesis fund i spv lt... 6.29 6.29 6.29 6.29 6.27
ca dawn investments 14.52 14.52 14.52 10.23 10.20
chestnut associates (ptc)... - - - - 1.43
fidelity funds - india fo... - 1.17 1.62 1.76 1.75
gaurav kapoor 2.62 2.62 2.62 2.62 2.61
llp 2.11 2.29 4.34 2.58 2.45
manish gupta 8.97 8.97 8.97 8.97 8.95
nadathur fareast pte ltd 22.03 22.03 22.03 22.03 21.96
rajesh bhaskaran nair 7.13 7.13 7.13 7.19 7.16
sanjay s parikh 5.01 5.01 5.01 5.02 5.00
sbi innovative opportunit... - - - - 1.39
smallcap world fund, inc - - 1.05 1.05 1.19
sycamore philanthropy (pt... - - - - 1.43
vida trustees private lim... - 2.34 2.34 2.34 2.33
aarabhi partners consulta... 2.11 2.11 2.11 2.11 -
chestnut associates (ptc)... - - 1.44 1.44 -
sycamore associates (ptc)... - - 1.44 1.44 -
sycamore philanthropy (pt... - 1.44 - - -
chestnut associates (ptc)... 1.44 - - - -
sycamore philanthropy (pt... 1.44 - - - -
vida trustees private lim... 2.34 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2024

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
Research Monarch Networth Capital

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q3FY25
Presentation Q3FY25

Company News

Indegene launches NEXT Medical Writing Automation 12 Jul, 11:31 AM Indegene partners with FAST India to scale up India’s biotech ecosystem 3 Jul, 2:10 PM Indegene informs about press release 3 Jul, 12:43 PM Indegene informs about analyst meet 22 May, 12:06 PM Indegene partners with Indian Institute of Cerebral Palsy 19 May, 12:20 PM Indegene informs about press release 19 May, 11:45 AM Indegene partners with Indian School of Public Policy 7 May, 11:07 AM Indegene - Quaterly Results 28 Apr, 7:48 PM Indegene - Quaterly Results 28 Apr, 7:48 PM Indegene informs about updates 24 Apr, 5:23 PM Indegene launches new center in London 20 Mar, 9:27 AM Indegene recognized among Financial Times High-Growth Companies in Asia-Pacific 2025 18 Mar, 4:43 PM Indegene informs about notice of postal ballot 17 Mar, 4:55 PM Indegene informs about press release 10 Mar, 11:39 AM Indegene launches Cortex 24 Feb, 1:00 PM Indegene informs about board meeting proceedings 24 Feb, 12:23 PM Indegene informs about press release 24 Feb, 11:48 AM Indegene informs about investor meet 20 Feb, 5:12 PM Indegene informs about board meeting 18 Feb, 5:30 PM Indegene launches new entity in Spain 6 Feb, 2:42 PM Indegene - Quaterly Results 30 Jan, 5:37 PM Indegene - Quaterly Results 30 Jan, 5:37 PM Indegene - Quaterly Results 30 Jan, 5:37 PM Indegene informs about outcome of board meeting 30 Jan, 5:31 PM Indegene informs about disclosure 23 Jan, 9:39 AM Indegene informs about press release 17 Jan, 4:26 PM Indegene informs about press release 17 Dec, 11:02 AM Indegene informs about press release 9 Dec, 9:59 AM Indegene informs about disclosures 6 Dec, 12:32 PM Indegene informs about disclosures 6 Dec, 12:31 PM Indegene informs about disclosure 5 Dec, 5:15 PM Indegene informs about disclosure 4 Dec, 2:38 PM Indegene informs about disclosure 26 Nov, 10:02 AM Indegene submits analyst meet intimation 25 Nov, 5:29 PM Indegene informs about disclosure 25 Nov, 2:04 PM Indegene unveils new center in Hyderabad 18 Nov, 2:29 PM Indegene - Quaterly Results 28 Oct, 7:04 PM Indegene - Quaterly Results 28 Oct, 7:04 PM Indegene informs about press release 10 Oct, 12:42 PM Indegene informs about Investor Meet 16 Sep, 4:20 PM Indegene informs about trading window closure 2 Aug, 2:55 PM Indegene - Quaterly Results 1 Aug, 8:05 PM Indegene - Quaterly Results 1 Aug, 8:05 PM Indegene informs about press release 11 Jul, 2:37 PM Indegene enters into strategic collaboration with Microsoft 11 Jul, 2:24 PM Indegene collaborates with Indian Institute of Science, Ignite Life Science Foundation 12 Jun, 2:45 PM Indegene informs about outcome of board meeting 30 May, 11:47 AM Indegene informs about disclosure 16 May, 2:50 PM Indegene coming with IPO to raise upto Rs 1881 crore 3 May, 3:42 PM Indegene files Rs 3,200 crore IPO papers with SEBI 16 Dec, 10:04 AM

Indegene Stock Price Analysis and Quick Research Report. Is Indegene an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Indegene stock price today is Rs 575.2. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Indegene . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Indegene has a PE ratio of 76.1652542372882 which is high and comparatively overvalued .

  • Share Price: - The current share price of Indegene is Rs 575.2. One can use valuation calculators of ticker to know if Indegene share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Indegene has ROA of 10.8784 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Indegene has a Current ratio of 6.4274 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Indegene has a ROE of 13.0695 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Indegene has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Indegene has reported revenue growth of 4.5907 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Indegene for the current financial year is 16.5051207022677 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Indegene is Rs 2 and the yield is 0.3461 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Indegene is Rs 7.552 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Indegene in Ticker for free. Also, one can get the intrinsic value of Indegene by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Indegene
X